Selank

Selank is a synthetic peptide analogue derived from tuftsin, a naturally occurring immunomodulatory peptide. It is commonly researched for its potential interaction with neuroregulatory, stress-response, neurotransmitter, and cognitive-performance pathways.

Research involving Selank frequently investigates its potential interaction with:

• GABAergic neurotransmitter signaling
• Stress-response and resilience-related pathways
• Neuroendocrine regulation
• Cognitive-performance and focus-related signaling
• Emotional-regulation pathways
• Neuroplasticity and neuroprotective research

Unlike traditional sedative or stimulant-based compounds, Selank is researched for its broader neuroregulatory and neuromodulatory research profile involving neurotransmitter modulation, stress adaptation, cognitive-performance pathways, and neuroplasticity-related signaling.

Experimental models commonly investigate Selank in:

• Stress-response and resilience research
• Cognitive-performance and focus-related studies
• Mental-fatigue and cognitive-endurance models
• Neurorecovery and neuroprotective research
• Emotional-regulation and neuroendocrine pathways

Research also commonly explores Selank alongside compounds such as:

• Semax
• NAD+
• Noopept
• Neuroregulatory and nootropic research peptides

These combination protocols are investigated for complementary cognitive-performance, neuroregulatory, stress-response, and neuroprotective signaling pathways.

At BioPeptics, Selank is supplied in sterile lyophilized vial form for enhanced stability and is independently third-party tested for identity and purity verification.

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Research Applications

Stress-Response & Resilience Research

Selank is widely researched for its potential interaction with stress-response regulation and resilience-related pathways.

Research models commonly investigate:

• Stress-adaptation signaling
• Neuroendocrine-response pathways
• Resilience-focused cognitive models
• Mental-fatigue and recovery-related signaling
• Stress-related neuroregulatory mechanisms

Cognitive-Performance & Focus Research

Research involving Selank frequently explores its potential interaction with:

• Cognitive-performance and attention-related pathways
• Focus and concentration signaling
• Mental-endurance and productivity-related research
• Cognitive-workload adaptation models
• Task-engagement and executive-function pathways

Neurotransmitter & GABAergic Research

Because Selank is researched for its interaction with neurotransmitter pathways, experimental models commonly investigate:

• GABAergic signaling pathways
• Dopaminergic and serotonergic activity
• Neurochemical-regulation mechanisms
• Emotional-regulation and stress-response signaling
• Neurotransmitter-balance research

Neuroprotective & Neuroplasticity Research

Selank is also commonly researched in models involving:

• Neuroprotective signaling
• Neuroplasticity and neural-adaptation pathways
• Recovery-focused neuroscience models
• Cognitive-recovery and neuroregulatory research
• Brain-function and neuroregulatory studies

Mental-Fatigue & Cognitive-Endurance Research

Experimental models frequently investigate Selank in:

• Mental-fatigue and resilience studies
• Cognitive-endurance pathways
• Stress-related cognitive-performance research
• High-demand cognitive-workload models
• Neuroadaptation and recovery-focused protocols

Emotional-Regulation & Neuroendocrine Research

Research involving Selank commonly explores:

• Emotional-regulation pathways
• Stress-related neuroendocrine signaling
• Cortisol-related stress-response research
• Mood-related neuroregulatory mechanisms
• Behavioral-adaptation studies

Combination Nootropic & Neuroregulatory Research

Selank is frequently researched alongside:

• Semax
• NAD+
• Noopept
• Neuroregulatory and nootropic research peptides

These combination protocols are investigated for complementary:

• Cognitive-performance pathways
• Stress-response signaling
• Neuroprotective pathways
• Neuroplasticity-related signaling
• Neurotransmitter-related pathways

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Synergistic Research Applications

Selank is frequently researched alongside complementary nootropic, neuroregulatory, and neuroprotective compounds due to its broad stress-response and cognitive-performance research profile.

In experimental settings, combination protocols are commonly investigated for their potential interaction with:

• Neurotransmitter modulation
• Neuroplasticity-related signaling
• Cognitive-endurance pathways
• Emotional-regulation mechanisms
• Stress-response signaling
• Neuroregulatory pathways

With Semax

One of the most commonly researched combinations involves Selank and Semax.

Selank is commonly investigated for stress-response regulation, emotional-regulation pathways, and GABAergic signaling, while Semax is researched for cognitive-performance, focus-related, and neurotrophic pathways.

Research models explore whether this combination may influence:

• Focus and cognitive-performance signaling
• Stress-resilience and neuroregulatory pathways
• Neuroplasticity and neuroprotective signaling
• Mental-endurance and cognitive-workload adaptation
• Neurotransmitter-regulation pathways

With NAD+

Selank is also frequently researched alongside NAD+ in cognitive-performance and neurorecovery-focused protocols.

These combinations are investigated for complementary roles involving:

• Cellular-energy and mitochondrial-function pathways
• Stress-response and neuroprotective signaling
• Mental-performance and cognitive-endurance research
• Neurorecovery and neuroregulatory pathways
• Cognitive-workload adaptation models

With Noopept & Nootropic Research Compounds

Research involving Selank commonly explores combinations with:

• Noopept
• Racetam-related compounds
• Cholinergic-support research compounds
• Neuroregulatory peptides

These protocols investigate complementary:

• Cognitive-performance pathways
• Neurotransmitter-regulation signaling
• Memory-related pathways
• Neuroplasticity-related signaling

With Neurorecovery & Stress-Response Research Models

Because Selank is researched for its interaction with stress-response and neuroregulatory pathways, it is often included in broader neuroscience-focused protocols investigating:

• Stress-adaptation and resilience pathways
• Cognitive-endurance signaling
• Emotional-regulation mechanisms
• Neuroprotective and recovery-focused pathways
• Neuroplasticity and neural-adaptation research

Neuroregulatory Research Profile

Unlike traditional anxiolytic or stimulant-based compounds, Selank is researched for its broader neuroregulatory and neuromodulatory signaling profile involving:

• Neurotransmitter modulation
• Stress-response adaptation
• Cognitive-performance pathways
• Neuroplasticity-related signaling

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Technical Information

Compound Name:
Selank

Chemical Classification:
Synthetic Tuftsin-Derived Neuroregulatory Peptide

Composition

Selank is a synthetic peptide analogue derived from tuftsin, a naturally occurring immunomodulatory peptide.

It is commonly researched for its potential interaction with:

• Stress-response regulation
• Neurotransmitter modulation
• Cognitive-performance pathways
• Neuroregulatory signaling

Peptide Characteristics

• Synthetic tuftsin-derived peptide analogue
• Neuroregulatory and nootropic research peptide
• Commonly researched for stress-response and cognitive-performance pathways
• Investigated for GABAergic and neurotransmitter-related signaling
• Frequently studied in neuroplasticity and neuroprotective research models

Amino Acid Sequence:
Thr-Lys-Pro-Arg-Pro-Gly-Pro

Molecular Formula:
C₃₃H₅₇N₁₁O₉

Appearance:
White to off-white lyophilized powder

Solubility:
Water soluble

Research Category:
Nootropic and neuroregulatory research peptide

Common Research Areas

• Stress-response and resilience-focused research
• Cognitive-performance and focus-related studies
• Neurotransmitter and GABAergic signaling research
• Neuroplasticity and neuroprotective pathway investigations
• Mental-fatigue and cognitive-endurance models
• Emotional-regulation and stress-response research

Stability

Selank is typically supplied in lyophilized form to support peptide stability, purity, and long-term storage integrity during laboratory handling and research use.

For Research Purposes Only

Not intended to diagnose, treat, cure, or prevent any disease.

Selank (10mg) — Research Dosage Guidance

Stress-Response Research • Cognitive-Performance Research • Neuroregulatory Research

For Research Use Only

Reconstitution (Mixing)

• Add 2ml bacteriostatic water to the vial
• Inject slowly down the side of the vial
• Allow the peptide to dissolve naturally
• Swirl or roll gently if needed
• Do not shake the vial
• Protect from direct light

Storage Guidelines

• Lyophilized peptide: Store frozen at approximately −20°C when possible
• After reconstitution: Refrigerate at 2–8°C
• Do not refreeze after mixing
• Protect from excessive heat and direct sunlight

Concentration Guide

10mg mixed with 2ml bacteriostatic water provides an approximate concentration of:

• 5mg/ml
• Every 10 insulin units (0.1ml) ≈ 500mcg
• Every 1 insulin unit (0.01ml) ≈ 50mcg

Core Research Administration Guidelines

Commonly researched administration ranges include:

• Daily research range: 300–500mcg
• Frequency: Once daily
• Common administration method: Subcutaneous administration

Administration Considerations

• Maintain consistent administration timing when appropriate
• Rotate administration sites regularly
• Utilize sterile handling practices

Titration Protocol

Weeks 1–2 (Introductory Research Phase)

• Research amount: 300mcg daily
• Volume: 0.06ml
• U100 insulin syringe measurement: 6 units

Weeks 3–4 (Target Research Phase)

• Research amount: 500mcg daily
• Volume: 0.10ml
• U100 insulin syringe measurement: 10 units

Accuracy Note

For research amounts below 0.10ml, smaller-capacity insulin syringes may improve dosing precision in research settings.

Targeted Research Protocols

1. Stress-Response & Neuroregulatory Research

(Stress-response and GABAergic-signaling models)

• Research amount: 300mcg
• Frequency: Once daily
• Common timing: Morning or early afternoon
• Typical duration: 3–4 weeks

Research Notes

Lower-dose protocols are commonly researched in stress-response and neuroregulatory models.

2. Focus & Cognitive-Stability Research

(Attention, focus, and executive-function models)

• Research amount: 300–500mcg
• Frequency: Once daily
• Common timing: Morning
• Typical duration: 4 weeks

Research Notes

Frequently investigated in non-stimulant neuroregulatory and cognitive-performance research protocols.

3. Stress-Adaptation & Emotional-Regulation Research

(Stress-resilience and neuroendocrine-response models)

• Research amount: 500mcg
• Frequency: Once daily
• Common timing: Morning
• Typical duration: 4–6 weeks

Research Notes

Often investigated in broader cognitive-performance and neuroregulatory research protocols.

4. Neurorecovery & Cognitive-Recovery Research

(Mental-fatigue and neuroadaptation-focused models)

• Research amount: 300–500mcg
• Frequency: Once daily
• Typical duration: 4 weeks

Research Notes

Gradual titration protocols are commonly utilized in neurorecovery-focused research settings.

5. Maintenance & Long-Term Neuroregulatory Research

• Research amount: 300mcg
• Frequency: 3–5 days weekly
• Duration: Variable depending on research objectives

Research Notes

Lower-frequency protocols are commonly researched following full cognitive-performance cycles.

Cycle & Scheduling Options

• Standard cycle: Commonly researched as 4 weeks on / 4 weeks off
• Alternate schedule: 5 days on / 2 days off weekly
• Repeat cycles may vary depending on research objectives

Protocol Overview

Administration Guidance

• Clean vial and administration site with alcohol
• Draw research amount and remove air bubbles
• Administer slowly using sterile technique
• Rotate administration areas regularly
• Utilize a new sterile syringe for each administration

Important Research Notes

• Utilize sterile single-use administration equipment
• Store reconstituted peptide refrigerated at 2–8°C
• Protect from excessive heat and direct sunlight
• Do not shake after mixing
• Avoid repeated contamination of the vial during handling

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Possible Side Effects

Observed in Research Settings

Selank is generally regarded in research settings as a well-tolerated neuroregulatory peptide with a stress-response and cognitive-performance research profile.

Observed responses may vary depending on:

• Research amount
• Administration frequency
• Protocol duration
• Neurochemical sensitivity
• Individual physiological response

Commonly Reported Research Observations

• Mild headaches
• Temporary relaxation-related observations
• Mild drowsiness or fatigue in sensitive research models
• Temporary focus- or alertness-related observations
• Light-headedness
• Mild nausea or digestive discomfort
• Administration-site redness or irritation

Neuroregulatory & Neurotransmitter Research Considerations

Because Selank is researched for its interaction with GABAergic and neurotransmitter-related pathways, some research settings may observe:

• Variability in stress-response signaling
• Temporary mental-performance–related observations
• Altered focus or concentration-related observations
• Temporary mood-related observations
• Increased sensitivity in stimulant- or neurotransmitter-sensitive research models

Stress-Response & Neuroendocrine Research Considerations

Research involving Selank commonly investigates pathways associated with stress adaptation and neuroendocrine regulation.

Some experimental models may observe:

• Temporary wakefulness-pattern changes
• Variability in stress-resilience observations
• Temporary relaxation-related observations
• Individual variability in neuroregulatory response patterns

Administration & Handling Considerations

Improper storage, reconstitution, or administration techniques may increase the likelihood of:

• Administration-site irritation
• Local inflammation
• Reduced peptide stability
• Reduced compound integrity

Additional Research Notes

• Higher research amounts do not necessarily produce proportionally greater effects and may increase the likelihood of side effects
• Individual responses may vary depending on stress levels, sleep quality, concurrent nootropics or stimulants, and overall neurochemical sensitivity
• Combination protocols involving Semax, NAD+, Noopept, or other neuroregulatory compounds may influence overall cognitive and neurochemical response patterns

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.

Use With Caution in Research Contexts

Because Selank is researched for its interaction with neuroregulatory, neurotransmitter, GABAergic, and stress-response pathways, research involving complex neurological, mood-related, psychiatric, cardiovascular, or neuroendocrine conditions may warrant additional monitoring and individualized evaluation.

Additional Monitoring May Be Considered In Research Models Involving:

• Anxiety-spectrum or stress-response research models
• Neurological sensitivity or chronic migraines
• Sleep-related disorders or significant insomnia
• Mood-related or psychiatric conditions
• Dopaminergic or neurotransmitter-related sensitivity
• Hormonal or neuroendocrine-related disorders
• Cardiovascular or cardiometabolic-related conditions
• Multiple concurrent nootropic, stimulant, or neuroregulatory compounds

Carefully Evaluate Research Models With:

• Known hypersensitivity to peptide compounds
• Severe uncontrolled mood-related, psychiatric, or neurological conditions
• Severe uncontrolled cardiovascular disease
• Active severe systemic illness
• Pregnancy and breastfeeding research contexts

Additional Research Considerations

Because Selank may influence neurotransmitter, GABAergic, and stress-response signaling pathways, research protocols may warrant monitoring of:

• Sleep-quality and wakefulness-related observations
• Stress-response variability
• Mood-related observations
• Cognitive-performance and focus-related responses
• Overall individual tolerability and neuroregulatory response

Combination protocols involving Semax, NAD+, Noopept, stimulants, or other neuroregulatory compounds may further influence cognitive and neurochemical response patterns.

Important Notice

Selank is supplied strictly as a laboratory research compound and is not approved to diagnose, treat, cure, or prevent any disease.

For Research Use Only

Selank is a synthetic neuroregulatory peptide researched for its potential interaction with stress-response regulation, cognitive-performance pathways, emotional-regulation signaling, and neurotransmitter-related mechanisms.

Research involving Selank commonly investigates its potential role in:

• Stress-response and resilience-related pathways
• Cognitive-performance and focus-related signaling
• GABAergic and neurotransmitter-related mechanisms
• Emotional-regulation and neuroregulatory pathways
• Neuroplasticity and neuroprotective research

Observed responses in research settings are generally mild and may include:

• Temporary relaxation-related observations
• Mild drowsiness or fatigue in sensitive research models
• Temporary focus- or alertness-related observations
• Mild digestive discomfort
• Administration-site irritation

Responses may vary depending on:

• Research amount
• Administration frequency
• Protocol duration
• Neurochemical sensitivity
• Individual physiological response

Because Selank is researched for its interaction with neurotransmitter and stress-response pathways, research involving complex neurological, mood-related, psychiatric, or neuroendocrine conditions may warrant additional monitoring and individualized evaluation.

Proper reconstitution, sterile handling practices, consistent administration protocols, and appropriate dosing schedules are important for maintaining peptide stability and minimizing variability during research use.

For Research Use Only

Not intended to diagnose, treat, cure, or prevent any disease.